Pfizer Inc. (NYSE: PFE) Share Price and News

$25.89 $-0.70 (-2.6%) Tuesday, 5 March 2024 at 8:00:00 am Australian Eastern Daylight Time

Pfizer Inc. Chart and Price Data

About Pfizer

Last updated 05-03-2024, 08:00:00am AEDT
Current Price $25.89
Change $-0.70 (-2.6%)
Close Price $25.89
Open Price $26.30
Bid $25.86
Ask $25.88
Day Range $25.61 - $26.46
Year Range $25.61 - $42.22
Volume 19,267
Average Volume 47,466,159
Market Cap $146,195,134,200.00
Earnings Per Share $0.36
  • Pfizer Inc. (NYSE: PFE)
    Latest News

    Two laboratory researchers in white coats and gloves sit side by side with scientific equipment and a computer screen conducting medical related research.
    International Stock News

    Why BioNTech trounced the Market on Tuesday

    Shareholders might be getting a small present from the company before long.

    Read more »

    The letters ETF on wooden cubes with golden coins on top of the cubes and on the ground
    ETFs

    3 ASX ETFs that could give investors easy exposure to the US markets

    Some easy ETFs for US exposure...

    Read more »

    A medical researcher in a white coat holds laboratory equipment and smiles.
    International Stock News

    Moderna's teen COVID-19 vaccine trial hits high marks

    The company should submit its request for the FDA to authorize the use of its vaccine in those 12 and…

    Read more »

    Medical asx share price fall represented by worried looking patient awaiting vaccine injection
    International Stock News

    Australia eyes Moderna (NASDAQ:MRNA) COVID-19 vaccine delivery

    The Moderna Inc (NASDAQ: MRNA) share price slipped overnight, despite the company announcing a deal with the Australian government.

    Read more »

    a doctor looking up at question marks
    Healthcare Shares

    What the Federal Budget could mean for CSL (ASX:CSL) shares

    How shares in Australia's only vaccine manufacturer CSL Limited (ASX: CSL) might be affected by 2 key Federal Budget initiatives.

    Read more »

    health prffesional giving someone a vaccine
    International Stock News

    Pfizer and BioNTech's COVID-19 vaccine authorized by the FDA for adolescents

    Parents are pleased, but the move won't change much for the drug companies from a financial perspective.

    Read more »

    woman carrying out an experiment with a pipette and petri dish
    International Stock News

    If Pfizer's vaccine is a winner, why did this analyst downgrade its stock?

    Mizuho Securities' Vamil Divan expresses concern about the company's post-coronavirus future.

    Read more »

    Female patient receives Pfizer covid vaccine administered by female doctor
    International Stock News

    Moderna just made the Pfizer vaccine's biggest weakness an even bigger one

    Both vaccines do an impressive job of providing protection against COVID-19. But Moderna's is much easier to get from production…

    Read more »

    People marching and holding up anti covid vaccine signs
    Healthcare Shares

    Only 40% of Australians want the AstraZeneca vaccine. What could this mean for CSL (ASX:CSL)?

    Only 40% of Australians are willing to have the AstraZeneca vaccine. What, if anything, could this mean for CSL Limited…

    Read more »

    asx share price rebound represented by wooden blocks spelling rebound with coins on top
    Healthcare Shares

    Why the CSL (ASX:CSL) share price has rebounded 13% since March

    The CSL Limited (ASX: CSL) share price is rebounding following recent developments. We take a closer look in what could…

    Read more »

    woman waering face mask holding vial of covid-19 vaccine
    Share Market News

    Wesfarmers' (ASX:WES) Bunnings open to hosting COVID vaccine hubs

    Wesfarmers Ltd (ASX: WES) subsidiary, Bunnings, is open to the government using its car parks for COVID-19 mass vaccination hubs.…

    Read more »

    asx share associated with COVID vaccine represented by lab tech drawing down syringe
    International Stock News

    Pfizer to develop mRNA vaccines without BioNTech

    The pharmaceutical heavyweight thinks it won't need any more help to whip up new mRNA-based vaccines.

    Read more »

    Profile

    since

    Note